CLINICAL IMPORTANCE OF TRANSPORTER-MEDIATED DRUG-DRUG INTERACTIONS: BASICS AND APPLICATIONS OF EVIDENCE-BASED DECISION MAKING

被引：0
|
作者：
Maeda, Kazuya [1 ]
机构：
[1] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Mol Pharmacokinet, Tokyo, Japan
来源：
DRUG METABOLISM REVIEWS | 2015年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
SC4.2
引用
收藏
页码：10 / 10
页数：1
相关论文
共 50 条
  • [21] ENDOGENOUS PROBES FOR TRANSPORTER-MEDIATED DRUG-DRUG INTERACTION
    Lai, Yurong
    DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) : S7 - S7
  • [22] Progress in the Quantitative Assessment of Transporter-Mediated Drug-Drug Interactions Using Endogenous Substrates in Clinical Studies
    Mochizuki, Tatsuki
    Kusuhara, Hiroyuki
    DRUG METABOLISM AND DISPOSITION, 2023, 51 (09) : 1105 - 1113
  • [23] Using Positron Emission Tomography to Study Transporter-Mediated Drug-Drug Interactions in Tissues
    Wulkersdorfer, B.
    Wanek, T.
    Bauer, M.
    Zeitlinger, M.
    Mueller, M.
    Langer, O.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (02) : 206 - 213
  • [24] Physiologically Based Pharmacokinetic Modeling of Rosuvastatin and Prediction of Transporter-Mediated Drug-Drug Interactions Involving Gemfibrozil
    Macwan, J. S.
    Lukacova, V.
    Fraczkiewicz, G.
    Bolger, M. B.
    Akhlaghi, F.
    Woltosz, W. S.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2015, 42 : S39 - S39
  • [25] Hepatic transporter-mediated pharmacokinetic drug-drug interactions: Recent studies and regulatory recommendations
    Izat, Nihan
    Sahin, Selma
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2021, 42 (2-3) : 45 - 77
  • [26] Transporter-mediated drug-drug interactions: advancement in models, analytical tools, and regulatory perspective
    Jala, Aishwarya
    Ponneganti, Srikanth
    Vishnubhatla, Devi Swetha
    Bhuvanam, Gayathri
    Mekala, Prithvi Raju
    Varghese, Bincy
    Radhakrishnanand, Pullapanthula
    Adela, Ramu
    Murty, Upadhyayula Suryanarayana
    Borkar, Roshan M.
    DRUG METABOLISM REVIEWS, 2021, 53 (03) : 285 - 320
  • [27] Transporter-Mediated Drug-Drug Interactions Involving OATP Substrates: Predictions Based on In Vitro Inhibition Studies
    Yoshida, K.
    Maeda, K.
    Sugiyama, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (06) : 1053 - 1064
  • [28] Comment on the Article “Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions”
    Sibylle Neuhoff
    Geoff T. Tucker
    Pharmaceutical Research, 2013, 30 : 1467 - 1468
  • [29] Comment on the Article "Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions"
    Neuhoff, Sibylle
    Tucker, Geoff T.
    PHARMACEUTICAL RESEARCH, 2013, 30 (06) : 1467 - 1468
  • [30] Quantitative evaluation of transporter-mediated drug-drug interactions based on a clearance concept and in vitro kinetic parameters
    Yoshida, Kenta
    Maeda, Kazuya
    Kotani, Naoki
    Sugiyama, Yuichi
    DRUG METABOLISM REVIEWS, 2011, 43 : 51 - 51
12345